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Abstract
Background: The adaptor protein RACK1 (receptor of activated kinase 1) was originally identified as an anchoring 
protein for protein kinase C. RACK1 is a 36 kDa protein, and is composed of seven WD repeats which mediate its 
protein-protein interactions. RACK1 is ubiquitously expressed and has been implicated in diverse cellular processes 
involving: protein translation regulation, neuropathological processes, cellular stress, and tissue development.
Results: In this study we performed a biophysical analysis of human RACK1 with the aim of obtaining low resolution 
structural information. Small angle X-ray scattering (SAXS) experiments demonstrated that human RACK1 is globular 
and monomeric in solution and its low resolution structure is strikingly similar to that of an homology model previously 
calculated by us and to the crystallographic structure of RACK1 isoform A from Arabidopsis thaliana. Both 
sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation techniques showed that RACK1 is 
predominantly a monomer of around 37 kDa in solution, but also presents small amounts of oligomeric species. 
Moreover, hydrodynamic data suggested that RACK1 has a slightly asymmetric shape. The interaction of RACK1 and Ki-
1/57 was tested by sedimentation equilibrium. The results suggested that the association between RACK1 and Ki-1/
57(122-413) follows a stoichiometry of 1:1. The binding constant (KB) observed for RACK1-Ki-1/57(122-413) interaction 
was of around (1.5 ± 0.2) × 106 M-1 and resulted in a dissociation constant (KD) of (0.7 ± 0.1) × 10-6 M. Moreover, the 
fluorescence data also suggests that the interaction may occur in a cooperative fashion.
Conclusion: Our SAXS and analytical ultracentrifugation experiments indicated that RACK1 is predominantly a 
monomer in solution. RACK1 and Ki-1/57(122-413) interact strongly under the tested conditions.
Background
The adaptor 36 kDa protein RACK1 (receptor of acti-
vated kinase 1) was originally identified as an anchoring
protein for protein kinase C and contains seven WD
repeats that mediate its protein-protein interactions [1,2].
It is also found to be up-regulated in human carcinomas
and during tissue regeneration after ischemic renal injury
[3,4]. Furthermore, RACK1 has been functionally impli-
cated in the development of cardiac hypertrophy,[5] in
the increase of focal adhesion[6] and regulation of cell
adhesion [7]. Also, recent data suggest that RACK1 may
affect gene expression through translation regulation and
assembly activation of ribosomes [8-10]. Overall, these
data suggest that RACK1 is a multi-purpose protein
whose regulatory roles may impact various functional
contexts.
It has been reported that RACK1 interacts with several
molecules including β PKC β;[11] Src;[12] β integrins;[13]
PDE4D5;[14] STAT1[15] and the regulatory protein Ki-1/
57, [16,17] a cytoplasmic and nuclear protein initially
identified in malignant cells from Hodgkin's lymphoma
[18,19]. Recent studies showing its phosphorylation, argi-
nine methylation and interaction with other regulatory
proteins, suggest that the functional role of Ki-1/57 in
human cells seems to be related to splicing regulation and
other events in RNA metabolism [16,20,17,21].
RACK1 is a member of the family of β-propeller pro-
teins and the first member of this protein family whose
structure has been determined was the β-subunit of the
mammalian heterotrimeric G protein [8,22]. Significant
sequence similarity with the G protein β-subunit has led
to the prediction that RACK1 may also adopt a seven-
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bladed β-sheet propeller [22,23]. This suggests the avail-
ability of multiple protein interaction surfaces. We previ-
ously modeled the three-dimensional structure of human
RACK1[24] and the crystal structure of a RACK1
ortholog from Arabidopsis thaliana was recently eluci-
dated with a resolution of 2.4 Å (PDB entry 3md0) [25].
Here, we analyzed the structural properties of human
RACK1 in solution through a set of biophysical
approaches. We showed that RACK1 is a predominantly
monomeric protein in solution accordingly to data
obtained from analytical ultracentrifugation (AUC) and
small angle X ray scattering (SAXS) experiments. We
restored the human RACK1 envelope from SAXS curves
through ab initio approaches and compared it with previ-
ously obtained related structures. These results suggest a
strong similarity between the structures of human
RACK1 and RACK1 isoform A from Arabidopsis thali-
ana, in accordance with the high conservation between
both amino acids sequences. The functional activity of
RACK1 in solution was also accessed through its binding
to Ki-1/57 protein. Fluorescence spectroscopy experi-
ments after titration of Ki-1/57(122-413) in solution with
RACK1 and sedimentation equilibrium experiments
showed that this association is strong and might involve
cooperative events.
Results and Discussion
Small Angle X-Ray Scattering results
Small-angle X-ray Scattering (SAXS) is an important
technique to obtain shape information and dimensional
parameters of biological macromolecules. Recently, the
application of SAXS to predict low resolution protein
structures gained even more importance with the
advances in the X-ray sources and computational meth-
ods. Since efforts to crystallize the human RACK1 have
been so far unsuccessful, an important step in the struc-
tural analysis of this protein is to perform X-ray scatter-
ing experiments to determine its conformation in
solution. The obtained intensity SAXS curve, normalized
by concentration, is presented in Figure 1A together with
the regularization fit obtained from the indirect Fourier
transform, which provided the pair distance distribution
function p(r) as described in the "materials and methods"
section. The resulting p(r) function is displayed in Figure
1B. In order to confirm the sample monodispersity, we
inspected the Guinier [26] approximation in its validity
region of the intensity curve. Guinier plots are displayed
in the inset of Figure 1A. The linearity of this region con-
firmed its monodispersity. The radius of gyration (Rg) of
the human RACK1 in solution was (20.8 ± 0.8) Å,
obtained using the Guinier approximation, and (20.6 ±
0.4) Å when calculated from the normalized second
moment of the p(r) function. Both Rg values are in very
close agreement. The maximum dimension (Dmax) of the
human RACK1 in solution provided by the p(r) function
was 60 Å. These data suggest that the protein is globular
and slightly oblate. The Kratky plot shown in the inset of
Figure 1B indicates that the protein conformation is quite
compact. Using a bovine serum albumin (BSA) solution
as a standard, the MM estimated for human RACK1 from
the SAXS data was ~40 kDa, which is very close to the
value of 37 kDa predicted from the amino acid sequence
of the recombinant protein. Based on these results we
conclude that the human RACK1 protein is a monomer
in solution.
Amino acids sequence analysis and comparison of known 
structures of RACK1 with experimental SAXS data
Human RACK1 has significant amino acid sequence sim-
ilarity to RACK1 isoform A from Arabidopsis thaliana
with 66% amino acid sequence identity and 78% amino
a c i d  s e q u e n c e  s i m i l a r i t y  ( F i g u r e  2 A ) .  T h i s  c o m p a r i s o n
suggests that both proteins may have a very similar three
dimensional structures. The alignment of both amino
acid sequences shows that the main difference between
the two proteins is located in their C-terminal region.
RACK1 orthologs have also been discovered in unicellu-
lar eukaryotes, such as Chlamydymonas,[27] and are
highly conserved in plants [28]. The high degree of
s e q u e n c e  c o n s e r v a t i o n  l i k e l y  r e f l e c t s  a  h i g h  d e g r e e  o f
functional conservation of the proteins in these species.
Although mutations are acquired through evolution the
preservation of the protein structure is usually higher
than the conservation of the amino acid sequence, since
the maintenance of the structure is pivotal for the pro-
teins function [29].
The crystallographic structure of the RACK1 isoform A
from Arabdopsis thaliana was recently solved and depos-
ited in the Protein Data Bank under the code 3dm0 [25].
Furthermore, the homology model of the human RACK1
was previously published, [24] allowing to calculate the
scattering intensity curve from the atomic coordinates of
these two structures as described in the "material and
methods" section. We compared these calculated curves
with the experimental data obtained for the human
RACK1 in solution. The results are shown in Figure 2B.
Both calculated curves compare quite well with the
experimental data, which indicates that the human
RACK1 may have a very similar structure compared to
both the homology model and the RACK1 isoform A
from Arabdopsis thaliana, although the calculated inten-
sity for the homology model (red curve) seems to be
nearer to the experimental data for human RACK1.
Low resolution models obtained from SAXS data
One of the great advantages of the SAXS technique is that
it offers the possibility of restoring the three dimensionalGonçalves et al. BMC Structural Biology 2010, 10:15
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molecular envelope from the experimental data. This
modeling can be improved when portions of the struc-
ture are already known, solving the possible ambiguities
resulting from the calculation. This seems to be the case
of the human RACK1, since both a homology model of
human RACK1 as well as the crystal structure of RACK1
from Arabidopsis thaliana, are available. Since we studied
the protein fused to a 6xHis tag at the N-terminal and we
already observed that the homology modeled human
RACK1 structure provided a calculated SAXS curve in
agreement with the experimental SAXS data, we restored
the human RACK1 molecular envelope using the method
of addition of missing loops. Fixing the known part of the
human homology model, we built dummy residues (DR)
chains in the position attached to the proper amino acids
in the N-terminal region of the structure. The number of
DRs was known from the amino acid sequence. Both pro-
grams CHADD and GLOOPY provided very similar
SAXS data based models for the human RACK1.
The resulting model is presented in Figure 2C (yellow
spheres) superimposed to the ab initio homology model
(ribbons representation). For the correct alignment of the
two models, we used the program SUPCOMB [30,31]. To
show the region of the ab initio model where the (6xHis
tag) was attached to the protein, the dummy elements are
shown as blue spheres. The intensity curve calculated
from the model (derived from SAXS data) is displayed in
the Figure 2B (black curve), showing, as expected, an
even better fit to the experimental data. These results
give a strong indication of the similarity of the structure
of human RACK1 and RACK1 isoform A from Arabdop-
sis thaliana and confirms the structure predicted by the
homology model of human of RACK1.
Analytical ultracentrifugation experiments
Aiming to gain further informations on the structural
parameters of human RACK1 in solution through its
hydrodynamic properties, we performed sedimentation
velocity experiments in an analytical ultracentrifuge
(AUC). All experiments were performed at 3 protein con-
centrations, 4 °C, and the data were analyzed by the Sed-
Fit software. Figure 3A show the continuous c(S)
distribution which suggests that the protein present one
predominant species and, at least, 3 other species in solu-
tion (Figure 3A, inset). RACK1 as monomer should be the
main particle in solution (~90% of the total mass) as
observed on the area under the c(S) curve ratio. RACK1
as dimer (~6%), tetramer (~2%) and a hexamer or octo-
mer (~2%), could be also observed in the c(S) curve (Fig-
ure 3A, inset). Moreover, these data are in accordance
which previous observations that RACK1 tends to oli-
gomerize and/or aggregate in multi-oligomer species
depending on the storage conditions, such as ionic
strength, protein concentration and temperature [24].
This property also forced us to include an ultracentrifu-
gation step before subjecting our samples to SAXS data
acquisition in order to solve problems with polydispersity
(for details see Materials and Methods section).
The predominant monomeric particle in solution
observed for RACK1 sedimentation velocity experiments
provided a s0
20,w of 3.00 ± 0.01 S as presented in Figure
3B. We estimated the diffusion coefficient by dynamic
light scattering at 4 °C and corrected it to standard condi-
tion (D20,w, Materials and Methods). Both s0
20,w and D20,w
were used to calculate the RACK1 MM through the s/D
ratio (Equation 1) and the result suggest that the predom-
Figure 1 Small Angle X-ray Scattering (SAXS) results. (A) Experimental scattering curve of 6xHis-RACK1 (open circles) and the theoretical fitting 
(solid line) by using the program GNOM. Inset: Guinier Region and linear regression (solid line) for Rg evaluation. (B) Pair distance distribution function 
p(r). Inset: Kratky plot.Gonçalves et al. BMC Structural Biology 2010, 10:15
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inant particle in solution was a monomer of around 37
kDa (Table 1). In spite of differences in the buffers used in
SAXS experiments (containing 20% of glycerol and
150mM of NaCl) and AUC experiments (3% of glycerol
and 500 mM of NaCl), the results of both techniques sug-
gest that RACK1 is a monomer in solution. Indeed, the
Figure 2 Sequence alignment and ab initio model for human 6xHis-RACK1 protein in solution. (A) Alignment between amino acid sequences 
of RACK1 from Homo sapiens (GI:83641897) versus RACK1A from A. thaliana (GI:30685669). The symbols: * showing identical residues, : residues with 
high similarity and residues with low similarity. (B) Experimental scattering curve of human 6xHis-RACK1 (open circles) and the calculated scattering 
intensity from the RACK1 from A. thaliana (solid green line) and Homo sapiens (solid red line) by using the program CRYSOL. The solid blue line repre-
sents the scattering intensity calculated from the ab initio model of 6xHis-RACK1. (C) Two orthogonal views of the homology model of human RACK1 
(cartoon representation with secondary structure elements) superposed to the three dimensional low resolution ab initio model (semi-transparent 
yellow surface) of the human RACK1, obtained from processing the SAXS data.Gonçalves et al. BMC Structural Biology 2010, 10:15
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polydispersity observed in the AUC experiments may be
artifactual and may have been caused by the lower glyc-
erol content in the AUC buffer, the larger incubation time
in this experiment (in comparison with the SAXS experi-
ments) and finally also the relatively higher protein con-
centration used here. All of these conditions may
promote the observed protein aggregation in the AUC
experiments.
Table 1 summarizes the RACK1 hydrodynamic proper-
ties calculated for a sphere of 37 kDa (RACK1's MM) and
the experimental data determined by dynamic light scat-
tering and sedimentation velocity. We also used the
RACK1 homology model previously calculated [24] to
obtain its hydrodynamic properties using HydroPro soft-
ware (see Material and Methods) [32]. Both D20,w and
s0
20,w determined experimentally were in accordance to
the hydrodynamic properties calculated for the homology
model, suggesting that it is a reasonable model for
RACK1 in solution. All hydrodynamic data, together with
the frictional ratio calculated by either SedFit software
(~1.4) or estimated from the ratio of ssphere to s0
20,w (~1.3),
suggest that RACK1 is a slightly asymmetric or distorted
particle.
Equilibrium sedimentation is an analytical ultracentrif-
ugation method based on the equilibrium between the
centrifugal and diffusional forces. It is a thermodynamic
technique that allows to obtain the MM of a particle inde-
pendently of its molecular shape and to perform protein
association studies [33]. RACK1 equilibrium sedimenta-
tion experimental data fitted with a model of a single spe-
cie system (variable MM) and resulted in a MM of around
46 kDa (data not shown), which suggested that human
RACK1 solutions contained monomers of 37 kDa and oli-
gomers, as also observed in sedimentation velocity exper-
iments. Thus, we fitted the equilibrium sedimentation
data using several models of self-associating systems.
Considering that the sedimentation velocity experiments
presented above suggested the presence of a monomer-
dimer-tetramer system (Equation 2), we used a model of
self-association to fit the sedimentation equilibrium data,
using the SedPhat software. The presence of the hexamer
or octomer, however was not considered for this fitting
analysis, because of their low molar concentration in the
human RACK1 solution used. Figure 4A (upper panel)
presents RACK1 at 0.3 mg/mL in equilibrium at 3 speeds
in which the data were fitted with the Equation 3. For
this, we fixed the monomer MM at 37.2 kDa. The lower
panel in Figure 4A, shows a residuals fitting dispersed
around zero, which points to a good fitting. As expected,
human RACK1 formed dimers and tetramers with KBM-D
of (2 ± 0.2) ± 105 M-1 and KBD-T of (6 ± 2) × 105 M-1,
respectively. Dissociation constant (KD) for monomer-
dimer (KDM-D) and dimer-tetramer (KDD-T) equilibrium
where of 51 ± 2 μM and 17 ± 9 μM, respectively.
Thus, our findings that RACK1 is predominantly a
monomer in solution seem at first to contrast with some
data found in the literature, that relate that human
RACK1 can engage in dimerization interaction in in vitro
pull-down assays and in vivo, using cross-linker experi-
ments [34]. A more recent study however, demonstrates
that such a RACK1 dimerization in vivo may depend cru-
cially on its previous phosphorylation, while dephospho-
rylation of RACK1 causes the disintegration of the
homodimeric complex [35] Altogether, these findings are
in good agreement with our results, since our bacterially
expressed RACK1 is not phosphorylated, whereas
RACK1 in human cells is likely to be phosphorylated and
regulated by phosphorylation. Therefore, the dephospho-
rylated RACK1 should present low KB while the phopho-
Figure 3 RACK1 sedimentation velocity experiments. (A) Sedi-
mentation velocity experiments were carried out at 4°C, 40,000 rpm 
(AN-60Ti rotor), and with scan data acquisition at 272 nm. Data were fit-
ted using SedFit software (Version 11.8). Figure displays the c(S) fitting 
for RACK1 at concentrations of 0.1, 0.2 and 0.3 mg/mL. The c(S) curves 
suggest that RACK1 present a predominant specie and three or four 
others species with higher sedimentation coefficients (inset) (B) Plots of 
s20,ω (of the predominant specie) versus protein concentration fitted by 
linear regression to calculate the s0 
20;w: 3.00 ± 0.01 Svedberg.Gonçalves et al. BMC Structural Biology 2010, 10:15
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rylated RACK1 may be able to dimerize with higher KB.
However, we cannot exclude that the relative low KBM-D
and KD-T described above may be an artifact induced by
the experimental conditions tested.
RACK1 binding activity in solution
We also used sedimentation equilibrium methods to
assess how functional RACK1 protein was in our experi-
mental conditions. Previously, we described the interac-
tion of RACK1 with the regulatory protein Ki-1/57 and
analyzed their interaction through spectroscopic meth-
ods [17,24]. We then used here a truncated form of Ki-1/
57 encompassing the amino acids 122-413 to obtain fur-
ther thermodynamic details of this association. We ana-
lyzed the absorbance data by the SedPhat program as
multi-speed equilibrium data and the results are pre-
sented in Figure 4B by using the Equation 3 presented
above for a hetero-association system with a stoichiome-
try between RACK1 and Ki-1/57(122-413) of 1:1 (Equa-
tion 4). The lower panel (Figure 4B) shows the residuals
fitting randomly dispersed around zero, which points to a
good data fitting. The KB observed for RACK1-Ki-1/
57(122-413) interaction was of around (1.5 ± 0.2) × 106
M-1 that resulted in a KD of 0.7 ± 0.1 μM. This data sug-
gest that the equilibrium interaction between these two
proteins is strong in the tested conditions. The KB for
RACK1-Ki-1/57(122-413) interaction is 7.5 times higher
than RACK1 KBM-D suggesting that, in the protein con-
centration assayed, around 91% of the RACK1 is in the
hetero-dimeric complex and that the concentration of
RACK1 as a homo-dimer must be lower than 0.01 μM
and could be neglected from this analysis. This highly
productive association may explain why around 54% of
clones restored from our yeast two-hybrid screenings
using Ki-1/57 as bait represented the RACK1 protein
[16].
Titration of Ki-1/57(122-413) to RACK1 solution was
carried out at 25 °C in 20 mM Tris-HCl (pH 7.5) and fol-
lowed by intrinsic fluorescence emission. However, we
did not observe any induced changes in the maximum
fluorescence emission wavelength upon Ki-1/57(122-
413) titration (Figure 5A). On the other hand, the titra-
tion curve presented two well defined regions (Figure 5,
inset) suggesting that the RACK1-Ki-1/57(122-413) inter-
action involves, at least, two effects: up to 0.2 μM of Ki-1/
57(122-413), it is possible to observe an initial fluores-
cence decrease probably due to fluorescence quenching.
At 0.3 μM of Ki-1/57(122-413), the emission fluorescence
increased nearly twice suggesting that RACK1 and/or Ki-
1/57(122-413) may undergo a conformational change
upon Ki-1/57(122-413) binding (Figure 5, inset). We can-
not explain this result, but we speculate that this intrigu-
ing effect may be a result of Ki-1/57(122-413) binding to
the human RACK1 surface where at least part of the Trp
residues seem to be exposed as our previous homology
model of RACK1 suggested [24]. These Trp residues may
be already quenched by the solvent and RACK1 associa-
tion with Ki-1/57(122-413) could lead the tryptophans to
a conformation able to show an increment in the total flu-
orescence intensity emission.
At concentrations higher than 0.3 μM the Ki-1/57 titra-
tion induced RACK1 fluorescence emission quenching
which follows a sigmoidal curve (Figure 5, inset), that rep-
resents another effect due to protein association. Figure
5B represents the difference of fluorescence intensity at
334 nm (F0 - F = θ) as function of Ki-1/57 concentration
range from 0.3 μM up to 1.4 μM. Adjusting this titration
c u r v e  w i t h  a  m o d i f i e d  H i l l  e q u a t i o n  ( E q u a t i o n  5 )  w e
could estimate the KD for the interaction between Ki-1/
57 and RACK1 as about 0.60 μM and the number of
cooperative sites n as 8 ± 1. This points to an apparent
cooperativity of the interaction, since the stoichiometry
Table 1: RACK1 hydrodynamic properties.
RACK1 Hydrodynamic property Predicted for a sphere DLS* AUC HydroPro of homology model SAXS
M (kDa) 37.2 36.4 ± 0.8& 36.4 ± 0.8& -4 0
s020,w (S) 4.01 - 3.00 ± 0.01 3.16 ± 0.02 -
D20,w (10-7cm2/seg) 9.6 7.7 ± 0.2 - 8.0 ± 0.1 -
Dmax (Å) - - - 63 ± 1 60
Rg (Å) - - - 20.0 ± 0.1 20.8 ± 0.8$
20.6 ± 0.4#
&from s/D ratio (Equation 1)
$: from Guinier approximation
#: from the normalized second moment of the p(r) function
* Dynamic light scatteringGonçalves et al. BMC Structural Biology 2010, 10:15
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determined by sedimentation equilibrium was 1:1. It is
also interesting to note that this KD corresponds to the
KD of RACK1\Ki-1/57(122-413) observed in sedimenta-
tion equilibrium experiments. These data emphasize that
the interaction between human RACK1 and Ki-1/57 was
strong in the experimental conditions tested.
The human RACK1 protein contains thirteen trypto-
phan residues, which yield strong signal fluorescence
emission intensities but also increase the complexity of
fluorescence emission spectra. Despite the high number
of Trp residues in the RACK1 structure, the homology
model developed for RACK1 suggests the presence of, at
least, two kinds of Tryptophans on RACK1: 1) the
exposed Trps on the RACK1 surface and 2) the buried or
partially buried Trps [24]. Thus, these different classes of
Trps may suffer distinct effects upon Ki-1/57(122-413)
binding: while some of them may be more protected, oth-
ers may be rather quenched. However, we cannot exclude
the participation of the 3 Trps on the Ki-1/57(122-413)
recombinant protein. Ki-1/57(122-413) has been
described as an intrinsically unfolded protein [36] and
therefore it could bind to RACK1 by several contact
Figure 4 RACK1 Sedimentation equilibrium experiments. (A) The 
figure shows the best fits of experimental data for 300 μg/mL of RACK1 
(4 °C) at 12000, 15000, and 18000 rpm with the self-association meth-
ods (SedPhat program - Material and Methods). The random distribu-
tion of the residuals (bottom panel) indicates that the fit is satisfactory. 
Sedimentation equilibrium data of RACK1 agree with a monomer 
structure with 37.2 kDa in equilibrium with of dimers and tetramers 
(see Results and Discussion for details). (B) Sedimentation equilibrium 
interaction between RACK1 and KI-1/57(122-413) was tested at 300 
μg/mL of both proteins at 12,000, 15,000, and 18,000 rpm and 4 °C. The 
data were fitted by self-association method (SedPhat program - Mate-
rial and Methods) and resulted in random distribution of the residuals 
(bottom panel) which indicates that the fit is satisfactory. The fitting 
data suggest that RACK1 and Ki-1/57(122-413) interacts with an affinity 
constant of (1.5 ± 0.2) × 106 M-1.
Figure 5 Titration of Ki-1/57(122-413) into RACK1 solution moni-
tored by fluorescence. (A) Fluorescence emission spectra titration of 
purified 6xHis RACK1 protein (1 μM) with titration of Ki-1/57 at 0.1 μM 
(black, filled square), 0.2 μM (black, filled circle), 0.3 μM (black, filled tri-
angle), 0.5 μM (open, white triangle) and 1 μM (open, white circle). The 
excitation wavelength was 295 nm and spectra were background cor-
rected. Inset: Area under curve (AUC) of RACK1 fluorescence emission 
spectrum in function of Ki-1/57(122-413) concentration. The arrow in-
dicates the increase on the RACK1 fluorescence signal at Ki-1/57(122-
413) 0.3 uM. (B) The titration curve was represented as difference of flu-
orescence intensity at 334 nm θ (black, filled square) as function of Ki-
1/57(122-413) concentration in the range from 0.3 μM and 1.4 μM and 
fitted with the modified Hill equation (Equation 5). The dashed line 
represents the fitting curve. The KD between RACK1 and Ki-1/57(122-
413) was of around 0.60 μM which corresponds to the dissociation 
constant of RACK1\Ki-1/57(122-413) observed in sedimentation equi-
librium experiments. The number of cooperative sites n was 8 ± 1.Gonçalves et al. BMC Structural Biology 2010, 10:15
http://www.biomedcentral.com/1472-6807/10/15
Page 8 of 12
points, possibly inducing conformational changes on
either protein. The sigmoidal titration curve observed
may be explained by possible cooperative effects in the
binding of the two proteins. However, more detailed
emission fluorescence or other spectroscopic experi-
ments are required to address this newly raised issue.
Conclusion
Human RACK1 has significant amino acid sequence and
structurally similarity to RACK1 isoform A from Arabi-
dopsis thaliana. Analytical ultracentrifugation experi-
ments showed that human RACK1 has similar
hydrodynamic properties to that predicted to homology
model previously developed. Moreover, the SAXS data
demonstrated that the human RACK1 in solution may
have the same or very similar molecular envelope as that
of the RACK1 isoform A from Arabidopsis thaliana. Both
techniques also showed that the homology model previ-
ously proposed by shows a good agreement with the
experimental data presented here [24].
The hydrodynamic properties of the human RACK1
were established by both sedimentation velocity and
dynamic light scattering. The samples presented an
apparent aggregation in the hydrodynamic experiment
and they showed polydisperse behavior. Although the
equilibrium sedimentation analytical ultracentrifugation
results indicated a tendency of the protein for di- and
tetramerization, the data showed that human RACK1 is
predominantly a monomer in solution (over 90%). SAXS
data also confirmed the human RACK1 monomeric con-
formation in solution, although we previously adjusted
the glycerol content in the buffer and centrifuged the
sample to assure its monodispersity. This condition was
checked by DLS before the SAXS experiments (data not
shown).
The interaction of RACK1 with the Ki-1/57(122-413) is
strong and follows the stoichiometry of 1:1 as observed
by sedimentation equilibrium experiments. RACK1 is a
Trp-rich protein and its fluorescence emission spectrum
presents a maximum of around 334 nm suggesting that
some of these Trp are exposed to the solvent. The inter-
action of RACK1 with the Ki-1/57(122-413) monitored
by fluorescence emission spectroscopy agreed with the
interaction strength observed in the sedimentation equi-
librium experiments. Furthermore, the titration curve
resembles a sigmoidal curve suggesting a cooperative
effect in the interaction of RACK1 with the Ki-1/57(122-
413). Considering that Ki-1/57(122-413) is an intrinsi-
cally unfolded protein,[36] its interaction with RACK1
may involve several binding sites and seems to induced
conformational changes upon binding.
Methods
Plasmid constructions
Cloning of the cDNA coding for RACK1 full-length into
the pET-28a plasmid (Novagen/EMD Biosciences, San
Diego, CA) was performed as described previously [16].
The recombinant vector pET-28a-RACK1 expresses a
construct containing 24 additional amino acids at the N-
terminal of RACK1. These extra residues encopass the 6
× His-tag and other poly-linker encoded amino acids.
cDNA encoding human Ki-1/57 protein fragments was
amplified by PCR and then directionally cloned into the
bacterial expression pPROEx (Invitrogen, Carlsbad,
USA), as previously described [36].
Expression and purification of recombinant proteins
BL21(Δ SlyD) strain (Invitrogen) was transformed with
recombinant pET28a- RACK1 vector and grown in LB
medium with 30 ug/ml of kanamycin. When reaching the
logarithmic growth phase the recombinant bacteria were
induced for protein production with 1.7 mM of isopro-
pyl-b-D-thiogalactoside (IPTG) at 30 °C for 4 h. After
harvesting (6000 × g, 10 min), the bacterial cells were
resuspended and incubated for 40 min at 4 °C in lysis buf-
fer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 20% glyc-
erol, 1 mg/ml lysozyme, 1 mM phenylmethylsulfonyl
fluoride, and 0.05 mg/ml DNase. Additional pellet dis-
ruption was performed by 10 cycles of sonication in an
ice bath, followed by centrifugation at 18 000 × g, 4 °C for
30 min. The obtained supernatant was loaded onto a
HiTrap Chelating HP column (Ge Healthcare) and eluted
by a gradient of 0-400 mM imidazole. The obtained Ni2+-
affinity purified fractions were pooled and dialyzed
against the buffer: 50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 20% glycerol.
To obtain protein preparations free of degradation and
up to 95% of purity, Ki-1/57(122-413) was purified in two
steps as follows as described previously [36]. The concen-
tration of the recombinant protein was spectroscopically
determined using the calculated extinction coefficient for
the denatured proteins [37].
SAXS experiments
The SAXS experiments were performed at the D02A-
SAXS2 beamline of the Laboratório Nacional de Luz
Síncrotron (LNLS, Campinas, Brazil). Before the analysis,
the samples of human RACK1 were centrifuged at
356,000 × g for 30 min at 18 °C to remove any possible
aggregates. The composition of the buffer solution was
adjusted to avoid aggregation, [20 mM Tris-HCl (pH 7.5),
150 mM NaCl, 20% glycerol]. Dynamic light scattering
(DLS) was used to test the monodispersity of the solu-
tion. Measurements were performed with a monochro-Gonçalves et al. BMC Structural Biology 2010, 10:15
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matic X-ray beam with a wavelength of λ = 1.488 Å and
the X-ray scattering patterns were recorded using a two-
dimensional position-sensitive MARCCD detector. The
sample-to-detector distances were set at 506.8 mm and
1722.5 mm, corresponding to the scattering vector range
of 0.01 < q < 0.50Å-1 where q is the magnitude of the q-
vector defined by q = (4π/λ)sinθ (where 2θ is the scatter-
ing angle). Three successive frames of 300 s each were
recorded for each sample. The scattering data from the
buffer were recorded before and after the measurement
of each sample. The experiments were performed with
two different sample concentrations: 1.95 and 2.54 mg/
mL. The sample and buffer intensity curves were individ-
ually corrected for detector response and scaled by the
incident beam integrated intensity and the sample
absorption. Subsequently, the buffer scattering was sub-
tracted from the corresponding sample scattering. The
resulting curves were inspected for radiation-induced
damage, but no such effect was observed. A 5 mg/ml BSA
(66 kDa) solution in the same sample buffer was used as
MM standard sample to estimate the MM of RACK1.
This value was inferred from the ratio of the extrapolated
values of the intensity at the origin, I(0), from both sam-
ple and BSA solutions scattering [38,39].
The initial analyses of the SAXS data were performed
following the standard procedures. The radius of gyration
and the forward scattering intensity I(0) were obtained
from the Guinier approximation [26,40,41] where we
assumed that the intensity can be represented as I(q) =
I(0)exp(-(qRg)2/ 3 )  a t  v e r y  s m a l l  v a l u e s  o f  q  ( qRg  < 1).
Thereupon, the pair distance distribution function p(r)
was calculated by indirect Fourier transform of the scat-
tering intensity through a regularization method imple-
mented in the program GNOM [42]. This p(r) function
also provided the I(0) and Rg values. These parameters
proved to be in agreement with those obtained from the
Guinier approximation. This function also allows deter-
mination of the maximum dimension of the protein in
solution since p(r > Dmax) = 0.
We compared the experimental scattering curve from
the human RACK1 protein with its calculated scattering
curve from the homology model from the human RACK1
and with the calculated curve from the crystallographic
structure of the RACK1 isoform A from Arabdopsis thal-
iana. The calculation of the scattering intensity from the
atomic coordinates of the latter structures was performed
using the program CRYSOL [43]. Since the sample we
studied was in a solution with 20% glycerol, we calculated
the electron density of the solvent for this condition
(0.3497 electrons/Å3). The contribution of the other com-
ponents of the buffer solution to the the electron density
of the water (0.3344 electrons/Å3) was considered negli-
gible, due to their low concentration.
Ab initio modeling from the SAXS data
The ab initio models of the human RACK1 in solution
were calculated from the SAXS data using the homology
model previously obtained. We used a modeling method
that is an extension of the original Dummy-Residues (DR)
approach [31]. It can be used when parts of the protein
are known and the location of the interface of the known
and missing parts is also known [44]. Here, as we studied
the protein fused to a 6xHis tag at the N-terminal, the
homology model of the human RACK1 is used as the
known part. The 6xHis tag is represented as a chain of
DRs attached to the proper residues (known from the
sequence) in this structure. We performed random modi-
fication in this chain of DRs using the simulated anneal-
ing method for global minimization of the scoring
function to provide the best fit to the experimental scat-
tering curve. This method is implemented in two pro-
grams: [44] CHADD and GLOOPY. Both programs are
similar but the second one takes into account the primary
structure (amino acid sequence) of the protein.
Analytical ultracentrifugation
Sedimentation velocity and equilibrium sedimentation
experiments were performed using a Beckman Optima
XL-A analytical ultracentrifuge and analyzed as previ-
ously described [45]. Briefly, sedimentation velocity
experiments were carried out at 4°C and 40,000 rpm
(AN-60Ti rotor) in buffer Tris-HCl 20 mM (pH 7.5), NaCl
500 mM and Glicerol 3% (0.404 M). Human RACK1 was
tested at 0.1, 0.2 and 0.3 mg/ml and absorbance data
acquisition was at 272 nm. The fitting of absorbance ver-
sus cell radius data was done using SedFit (Version 11.8),
which solves the Lamm equation in order to discriminate
the spreading of the sedimentation boundary from diffu-
sion [46,47]. The maximum of peaks of the c(S) curves
gave the apparent sedimentation coefficient (s). The fric-
tional ratio (f/f0) was the regularization parameter in fit-
ting routine. The relative amount of each particle in c(S)
curves was estimated by the integral of the area under
curve of each peak in the c(S) curve using SedFit software
(Version 11.8) and OriginPro® (Version 8). The software
Sednterp http://www.jphilo.mailway.com/download.htm
was used to estimate RACK1 partial specific volume at
20°C (Vbar= 0.7288 mL/g), buffer density at 4 °C (ρ =
1.02976 g/mL), buffer viscosity at 4 °C (η= 0.017934
poise), and also the ssphere and the Dsphere for a globular
protein of about 37.2 kDa (Table 1). This software was
also used to estimate the standard sedimentation coeffi-
cient (s20,w) for each protein concentration in order to
estimate the s20,w at 0 mg/mL of protein concentration
(s0
20,w) by linear extrapolation [45]. This procedure mini-
mizes interferences caused by temperature, viscosity and
molecular crowd [48]. The diffusion coefficient parame-Gonçalves et al. BMC Structural Biology 2010, 10:15
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ter, D, was obtained from dynamic light scattering with a
DynaPro-MS/X device (Protein Solutions) at 4°C. The
D20,w was calculated as described [49] in similar way that
described above to s20,w. The MM can be estimated from
the ratio of the s to D as indicated by the equation 1:
where R is the gas constant, T is the absolute tempera-
ture.
The HydroPro software [32] was applied to estimate the
standard diffusion coefficient (D20,w), standard sedimen-
tation coefficient (s20,w) and hydrodynamic maximum
distance (Dmax,h) from the RACK1 model previously
developed [24] in order to compare to the experimentally
hydrodynamic data.
Sedimentation equilibrium experiments were carried
out at 4°C and at three speeds as follow: 12,000, 15,000
and 18,000 rpm (AN-60Ti rotor). Scan data acquisitions
were taken at 280 nm after 12 h of centrifugation at each
speed, in which the equilibrium was checked by subse-
quent scans. Sedimentation equilibrium analysis involved
fitting of absorbance versus cell radius data using nonlin-
ear regression routine implemented by SedPhap software
(Version 6.5). The Self-Association method was used to
analyze the sedimentation equilibrium experiments using
several models of association for RACK1. As observed in
the sedimentation velocity experiments, RACK1 tends to
oligomerize, thus the self-association model described by
the equation 2 applied, where KBM-D and KBD-T are the
binding constant of monomer-dimer and dimer-tetramer,
respectively (see Results and Discussion section for
details).
Distribution of the protein along the cell, obtained in
the equilibrium sedimentation experiments, was fitted
with the following equation for associating system.
where C is the protein concentration at radial position
r, Cmononer,r0 is the protein concentration at radial position
r0 (initial radial position), ω  is the centrifugal angular
velocity, KB is the binding constant and n is the stoichi-
ometry. Equation 3 can be developed for equilibrium sys-
tems with more species.
Interaction between RACK1 (37.2 kDa) and the C-ter-
minal of Ki-1/57(122-413) (37.3 kDa) [36] was also tested
by equilibrium sedimentation. Both proteins were pre-
pared in the buffer Tris-HCl 20 mM (pH 7.5), NaCl 500
mM and Glicerol 3% (0.404 M) at 300 ug/mL (~8.0 μM)
and submitted to centrifugation in the same conditions
presented above. SedPhat software (Version 6.5) [50] was
used to fitting the hetero-association model following the
Equation 4 where KB is the binding constant between
RACK1 and the C-terminal of Ki-1/57(122-413). Again,
Equation 3 was used for fitting protein distribution along
the cell.
The software Sednterp was used to estimate the molar
absorbance of the folded protein at 280 nm for RACK1
(80.940 mol/L-1.cm-1) and the C-terminal of Ki-1/57(264-
413) (32.890 mol/L-1.cm-1). These parameters were used
in SedPhat software for hetero-association fitting.
Fluorescence spectroscopy
The experiments were performed with an Aminco Bow-
manR Series 2 (SLM-Aminco) spectrofluorimeter
equipped with a 450W lamp. Experiments were carried
out at 25 °C in 20 mM Tris-HCl (pH 7.5). The recombi-
nant proteins were analyzed at concentration of 1 μM.
The intrinsic Tryptophan fluorescence was investigated
with an excitation wavelength of 295 nm using a spectral
band pass of 4 nm for both excitation and emission. The
titration curve of RACK1 and Ki-1/57 was used to fit with
a modified Hill equation [51] to determine the KD of the
interaction as described above:
where F0 is the fluorescence intensity at 0.3 μM of Ki-1/
57, F is the fluorescence intensity at a given Ki-1/57 con-
centration (in μM), θ is the difference of fluorescence
intensity, θ0 is θ at 0.3 μM of Ki-1/57; θmax is θ at Ki-1/57
saturating concentration, and n is the number of coopera-
tive sites. The software OriginPro® (Version 8) was used to
this fitting routine.
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